Oncogene · 2013 · 44 citations · 19 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingDevelopmental Signaling PathwaysOncogenic Signaling PathwaysProtein Kinase CascadesReceptor Tyrosine Kinase OncogenesSignal Transduction In CancerAlveolar RhabdomyosarcomaCancer Signaling PathwaysCrk Family AdaptorsSh3 Domain InteractionsSh3 DomainsSrc Family KinasesTumor Cell Survival PathwaysTyrosine Kinase Receptors
To identify novel signaling pathways necessary for rhabdomyosarcoma (RMS) survival, we performed a loss-of-function screen using an inducible small hairpin RNA (shRNA) library in an alveolar and an embryonal RMS cell line. This screen identified CRKL expression as necessary for growth of alveolar RMS and embryonal RMS both in vitro and in vivo. We also found that CRKL was uniformly highly expressed in both RMS cell lines and tumor tissue. As CRKL is a member of the CRK adapter protein family that contains an SH2 and two SH3 domains and is involved in signal transduction from multiple tyrosine kinase receptors, we evaluated CRKL interaction with multiple tyrosine kinase receptor signaling pathways in RMS cells. While we saw no interaction of CRKL with IGFIR, MET or PI3KAKT/mTOR pathways, we determined that CRKL signaling was associated with SRC family kinase (SFK) signaling, specifically with YES kinase. Inhibition of SFK signaling with dasatinib or another SFK inhibitor, sarcatinib, suppressed RMS cell growth in vitro and in vivo. These data identify CRKL as a novel critical component of RMS growth. This study also demonstrates the use of functional screening to identify a potentially novel therapeutic target and treatment approach for these highly aggressive pediatric cancers.
19
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
Xiang H.-F. Zhang, Qiongqing Wang, William L. Gerald et al. · Cancer Cell · 2009 · 658 citations · Full text
Medicine, Cancer Biology, Oncology +16
A loss-of-function RNA interference screen for molecular targets in cancer
Vu N. Ngo, R. Eric Davis, Laurence Lamy et al. · Nature · 2006 · 606 citations
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
Richard J. Davis, Celina M. D’Cruz, Mark A. Lovell et al. · PubMed · 1994 · 599 citations
Life Sciences, Genetics, Oncology +17